To confirm this result, we used CRISPR/Cas9 to generate isogenic Eμ-Myc lymphoma cell lines that lack either BAK, BAX, or both of these effectors of apoptosis, as confirmed by western blotting (Fig. 2C). This evidence concerns the gene BAK1 and lymphoma.